Sagent Pharmaceuticals 2024-06-19 Health critical FDA
Health · FDA · Recall #FDA-D-0554-2024
Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx… Recall
Issued June 19, 2024 · Sagent Pharmaceuticals
In June 2024, Sagent Pharmaceuticals recalled the Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
What you should do
- 1 Stop using Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sagent Pharmaceuticals to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Sagent Pharmaceuticals
- Category
- Health
- Recall date
- June 19, 2024
- Units affected
- Not reported
- Sold at
- Nationwide within the USA.
- Recall number
- FDA-D-0554-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Sagent Pharmaceuticals has 2 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.